Neuroactive steroids after estrogen exposure in depressed postmenopausal women treated with sertraline and asymptomatic postmenopausal women

Archives of Women's Mental Health

Volumn 13, Issue 1, 2010, Pages 91-98

  Morgan, Melinda L ^a   Rapkin, Andrea J ^a   Biggio, Giovanni ^b   Serra, Mariangela ^b   Pisu, Maria Giuseppina ^c   Rasgon, Natalie ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c CNR   (Italy)

^d STANFORD UNIVERSITY   (United States)

Author keywords

Allopregnanolone; Dehydroepiandrosterone; Neuroactive steroids; Postmenopausal depression; Selective serotonin reuptake inhibitor

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; ESTRADIOL; ESTROGEN; NEUROACTIVE STEROID; PLACEBO; PRASTERONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; STEROID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG EXPOSURE; ESTROGEN ACTIVITY; FEMALE; HUMAN; MAJOR DEPRESSION; MENOPAUSAL SYNDROME; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; TRANSDERMAL PATCH; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

BRAIN; DEHYDROEPIANDROSTERONE; DEPRESSIVE DISORDER, MAJOR; DESOXYCORTICOSTERONE; ESTROGENS; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PREGNANOLONE; SEROTONIN UPTAKE INHIBITORS; SERTRALINE;

EID: 76449084876     PISSN: 14341816     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00737-009-0106-1     Document Type: Article

References (68)

1. ML Barbaccia S Lello T Sidiropoulou T Cocco RP Sorge A Cocchiarale V Piermarini AF Sabato M Trabucchi C Romanini 2000 Plasma 5alpha-androstane- 3alpha, 17betadiol, an endogenous steroid that positively modulates GABA (A) receptor function, and anxiety: a study in menopausal women Psychoneuroendocrinology 25 659 675 10.1016/S0306-4530(00)00017-2 1:CAS:528:DC%2BD3cXlsVOrtbw%3D 10938447 (Pubitemid 30628429)
2. E Barrett-Connor D von Muhlen GA Laughlin A Kripke 1999 Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: the Rancho Bernardo Study J. Am. Geriatr. Soc. 47 685 691 1:CAS:528:DyaK1MXktFOhsLo%3D 10366167
3. EE Baulieu 1991 Neurosteroids: a new function in the brain Biology of the cell/ under the auspices of the European Cell Biology Organization 71 3 10 1:CAS:528:DyaK3MXmt1emsrg%3D 1912947
4. F Bernardi M Pieri M Stomati S Luisi M Palumbo N Pluchino C Ceccarelli AR Genazzani 2003 Effect of different hormonal replacement therapies on circulating allopregnanolone and dehydroepiandrosterone levels in postmenopausal women Gynecol. Endocrinol. 17 65 77 1:CAS:528:DC%2BD3sXjt1yrsrY%3D 12724021
5. F Bernardi N Pluchino S Begliuomini E Lenzi M Palumbo M Luisi AR Genazzani 2004 Disadaptive disorders in women: Allopregnanolone, a sensitive steroid Gynecol. Endocrinol. 19 344 353 10.1080/09513590400018223 1:CAS:528:DC%2BD2cXhtVOmsrrP 15724809 (Pubitemid 40128852)
6. C Berr S Lafont B Debuire JF Dartigues EE Baulieu 1996 Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study Proc. Natl Acad. Sci. USA 93 13410 13415 10.1073/pnas.93.23.13410 1:CAS:528:DyaK28XmvFSnu7Y%3D 8917605 (Pubitemid 26382830)
7. CL Bethea NZ Lu C Gundlah JM Streicher 2002 Diverse actions of ovarian steroids in the serotonin neural system Front. Neuroendocrinol. 23 41 100 10.1006/frne.2001.0225 1:CAS:528:DC%2BD38XitFOntLs%3D 11906203 (Pubitemid 34121908)
8. M Birkhauser 2002 Depression, menopause and estrogens: is there a correlation? Maturitas 41 S3 8 10.1016/S0378-5122(02)00009-9 1:CAS:528:DC%2BD38XivVagtL0%3D 11955789
9. LS Cohen CN Soares JR Poitras J Prouty AB Alexander JL Shifren 2003 Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report Am. J. Psychiatry 160 1519 1522 10.1176/appi.ajp. 160.8.1519 12900318 (Pubitemid 41070931)
10. LS Cohen CN Soares H Joffe 2005 Diagnosis and management of mood disorders during the menopausal transition Am. J. Med. 118 Suppl 12B 97 93
11. A Concas P Follesa ML Barbaccia RH Purdy G Biggio 1999 Physiological modulation of GABA (A) receptor plasticity by progesterone metabolites Eur. J. Pharmacol. 375 225 235 10.1016/S0014-2999(99)00232-0 1:CAS:528: DyaK1MXks1Crs7g%3D 10443579 (Pubitemid 29317607)
12. P Diamond GR Brisson B Candas F Péronnet 1989 Trait anxiety, submaximal physical exercise and blood androgens Eur J Appl Physiol Occup Physiol 58 699 704 10.1007/BF00637379 1:STN:280:DyaL1M3ovFKrtQ%3D%3D 2525467 (Pubitemid 19142198)
13. D Erdincler G Bugay T Ertan E Eker 2004 Depression and sex hormones in elderly women Archives of Gerontology and Geriatrics 39 239 244 10.1016/j.archger.2004.03.008 1:CAS:528:DC%2BD2cXnslGitLg%3D 15381342 (Pubitemid 39277483)
14. TJ Fabian MA Dew BG Pollock CF Reynolds 3rd BH Mulsant MA Butters MD Zmud AM Linares M Trottini PD Kroboth 2001 Endogenous concentrations of DHEA and DHEA-S decrease with remission of depression in older adults Biol. Psychiatry 50 767 774 10.1016/S0006-3223(01)01198-2 1:CAS:528:DC%2BD3MXosFKksrw%3D 11720695 (Pubitemid 33086764)
15. P Follesa P Porcu C Sogliano M Cinus F Biggio L Mancuso MC Mostallino AM Paoletti RH Purdy G Biggio A Concas 2002 Changes in GABA (A) receptor gamma 2 subunit gene expression induced by long-term administration of oral contraceptives in rats Neuropharmacology 42 325 336 10.1016/S0028-3908(01)00187- 3 1:CAS:528:DC%2BD38XhvVCjs7g%3D 11897111 (Pubitemid 34230485)
16. AR Genazzani F Petraglia F Bernardi E Casarosa C Salvestroni A Tonetti RE Nappi S Luisi M Palumbo RH Purdy M Luisi 1998 Circulating levels of allopregnanolone in humans: gender, age, and endocrine influences J. Clin. Endocrinol. Metab. 83 2099 2103 10.1210/jc.83.6.2099 1:CAS:528: DyaK1cXjslCnsrs%3D 9626145 (Pubitemid 28496343)
17. AR Genazzani F Bernardi N Pluchino S Begliuomini E Lenzi E Casarosa M Luisi 2005 Endocrinology of menopausal transition and its brain implications CNS Spectrums 10 449 457 15908899
18. MC Hardoy M Serra MG Carta P Contu MG Pisu G Biggio 2006 Increased neuroactive steroid concentrations in women with bipolar disorder or major depressive disorder J. Clin. Psychopharmacol. 26 379 384 10.1097/01.jcp. 0000229483.52955.ec 1:CAS:528:DC%2BD28XntFSnu7Y%3D 16855455 (Pubitemid 44187639)
19. I Heuser M Deuschle P Luppa U Schweiger H Standhardt B Weber 1998 Increased diurnal plasma concentrations of dehydroepiandrosterone in depressed patients J. Clin. Endocrinol. Metab. 83 3130 3133 10.1210/jc.83.9.3130 1:CAS:528:DyaK1cXmt1ehurw%3D 9745415 (Pubitemid 28500946)
20. H Joffe LS Cohen 1998 Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge? Biol. Psychiatry 44 798 811 10.1016/S0006-3223(98) 00169-3 1:CAS:528:DyaK1cXnsFGrtrw%3D 9807636 (Pubitemid 28520219)
21. RT Khisti CT Chopde 2000 Serotonergic agents modulate antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice Brain Res. 865 291 300 10.1016/S0006-8993(00)02373-8 1:CAS:528:DC%2BD3cXjt1ejs7c%3D 10821935 (Pubitemid 30256011)
22. RT Khisti CT Chopde SP Jain 2000 Antidepressant-like effect of the neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one in mice forced swim test Pharmacol. Biochem. Behav. 67 137 143 10.1016/S0091-3057(00)00300-2 1:CAS:528:DC%2BD3cXoslGnsLk%3D 11113493
23. A receptor function Trends Pharmacol. Sci. 16 295 303 10.1016/S0165-6147(00)89058-6 1:CAS:528:DyaK2MXotF2ls74%3D 7482994
24. P Liu FF He WP Bai Q Yu W Shi YY Wu DJ He JH Xiao Y Zheng QP Liao 2004 Menopausal depression: comparison of hormone replacement therapy and hormone replacement therapy plus fluoxetine Chin. Med. J. 117 189 194 1:CAS:528:DC%2BD2cXjtFGktrw%3D 14975200
25. MD Majewska 1992 Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance Progress in Neurobiology 38 379 395 10.1016/0301-0082(92)90025-A 1:CAS:528: DyaK38XisVymsLw%3D 1349441
26. K Matsumoto V Uzunova G Pinna K Taki DP Uzunov H Watanabe JM Mienville A Guidotti E Costa 1999 Permissive role of brain allopregnanolone content in the regulation of pentobarbital-induced righting reflex loss Neuropharmacology 38 955 963 10.1016/S0028-3908(99)00018-0 1:CAS:528:DyaK1MXktlyjsLg%3D 10428414 (Pubitemid 29240612)
27. SH Mellon L Griffen 2002 Neurosteroids: Biochemistry and clinical significance Trends in Endocrine Metabolism 13 35 43 10.1016/S1043-2760(01) 00503-3 1:CAS:528:DC%2BD3MXpt1anu7w%3D (Pubitemid 36734014)
28. A Michael A Jenaway ES Paykel J Herbert 2000 Altered salivary dehydroepiandrosterone levels in major depression in adults Biol. Psychiatry 48 989 999 10.1016/S0006-3223(00)00955-0 1:CAS:528:DC%2BD3cXotVOjurs%3D 11082473 (Pubitemid 30811904)
29. AJ Morales JJ Nolan JC Nelson SS Yen 1994 Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age J Clin Endocrinol Metab. 78 1360 1367 10.1210/jc.78.6.1360 1:CAS:528:DyaK2cXksFSgs74%3D 7515387 (Pubitemid 24181005)
30. ML Morgan IA Cook AJ Rapkin AF Leuchter 2005 Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study J. Clin. Psychiatry 66 774 780 10.4088/JCP.v66n0617 1:CAS:528:DC%2BD2MXmtlKqtb8%3D 15960574
31. JE Morley F Kaiser WJ Raum HM Perry 3rd JF Flood J Jensen AJ Silver E Roberts 1997 Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone Proc. Natl Acad. Sci. USA 94 7537 7542 10.1073/pnas.94.14.7537 9207127 (Pubitemid 27345351)
32. MF Morrison T Ten Have EW Freeman MD Sammel JA Grisso 2001 DHEA-S levels and depressive symptoms in a cohort of African American and Caucasian women in the late reproductive years Biol. Psychiatry 50 705 711 10.1016/S0006-3223(01) 01169-6 1:CAS:528:DC%2BD3MXotFSlsr8%3D 11704078 (Pubitemid 33043774)
33. MF Morrison MJ Kallan T Ten Have I Katz K Tweedy M Battistini 2004 Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial Biol. Psychiatry 55 406 412 10.1016/j.biopsych.2003.08.011 1:CAS:528:DC%2BD2cXhtFWhsbk%3D 14960294 (Pubitemid 38199991)
34. N Orentreich JL Brind RL Rizer JH Vogelman 1984 Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood J Clin Endocrinol Metab 59 551 555 10.1210/jcem-59-3-551 1:CAS:528:DyaL2cXlsVCns7g%3D 6235241
35. H Osran C Reist CC Chen ET Lifrak A Chicz-DeMet L Parker 1993 Adrenal androgens and cortisol in major depression Am. J. Psychiatry 150 806 809 1:STN:280:DyaK3s3ktlCltQ%3D%3D 8386908
36. F Padberg F di Michele P Zwanzger E Romeo G Bernardi C Schule TC Baghai R Ella A Pasini R Rupprecht 2005 Plasma concentrations of neuroactive steroids before and after repetitive transcranial magnetic stimulation (rTMS) in major depression Neuropsychopharmacology 27 874 878 10.1016/S0893-133X(02)00355-X
37. SM Paul RH Purdy 1992 Neuroactive Steroids FASEB J. 6 2311 2322 1:CAS:528:DyaK38XhvVyisb4%3D 1347506
38. BE Pearson Murphy CM Allison 2000 Determination of progesterone and some of its neuroactive ring A-reduced metabolites in human serum J. Steroid Biochem. Mol. Biol. 74 137 142 10.1016/S0960-0760(00)00098-4 1:STN:280: DC%2BD3M%2FkvF2rsA%3D%3D 11086232 (Pubitemid 30845561)
39. G Pinna E Dong K Matsumoto E Costa A Guidotti 2003 In socially isolated mice, the reversal of brain allopregnanolone down-regulation mediates the anti-aggressive action of fluoxetine Proc Natl Acad Sci U S A 100 2035 2040 10.1073/pnas.0337642100 1:CAS:528:DC%2BD3sXhsFGrsbo%3D 12571361 (Pubitemid 36254569)
40. MG Pisu M Serra 2004 Neurosteroids and neuroactive drugs in mental disorders Life Sci. 74 3181 3197 10.1016/j.lfs.2003.12.002 1:CAS:528: DC%2BD2cXjt1Sitr8%3D 15094320 (Pubitemid 38501620)
41. N Pluchino AD Genazzani F Bernardi E Casarosa M Pieri M Palumbo G Picciarelli M Gabbanini M Luisi AR Genazzani 2005 Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels Gynecol. Endocrinol. 20 144 149 10.1080/09513590400021169 1:CAS:528:DC%2BD2MXjvVOltbY%3D 16019353 (Pubitemid 40694919)
42. NL Rasgon LL Altshuler LA Fairbanks JJ Dunkin C Davtyan S Elman AJ Rapkin 2002 Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women J. Clin. Psychiatry 63 Suppl 7 45 48 1:CAS:528:DC%2BD38XktFWlsr4%3D 11995778
43. NL Rasgon J Dunkin L Fairbanks LL Altshuler C Troung S Elman TE Wroolie MV Brunhuber A Rapkin 2007 Estrogen and response to sertraline in postmenopausal women with major depressive disorder: a pilot study J. Psychiatr. Res. 41 338 343 10.1016/j.jpsychires.2006.03.009 16697413 (Pubitemid 44854988)
44. E Romeo A Strohle G Spalletta F di Michele B Hermann F Holsboer A Pasini R Rupprecht 1998 Effects of antidepressant treatment on neuroactive steroids in major depression Am. J. Psychiatry 155 910 913 1:STN:280:DyaK1czisVSnsw%3D%3D 9659856
45. DR Rubinow PJ Schmidt CA Roca 1998 Estrogen-serotonin interactions: implications for affective regulation Biol. Psychiatry 44 839 850 10.1016/S0006-3223(98)00162-0 1:CAS:528:DyaK1cXnsFGrtrs%3D 9807639 (Pubitemid 28520222)
46. R Rupprecht 2003 Neuroactive steroids: mechanisms of action and europsychopharmacological properties Psychoneuroendocrinology 28 139 168 10.1016/S0306-4530(02)00064-1 1:CAS:528:DC%2BD38XpvVWmtrk%3D 12510009 (Pubitemid 36044075)
47. R Rupprecht F Holsboer 1999 Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives Trends Neurosci. 22 410 416 10.1016/S0166-2236(99)01399-5 1:CAS:528:DyaK1MXlsVygt74%3D 10441302 (Pubitemid 29453646)
48. PJ Schmidt L Nieman MA Danaceau MB Tobin CA Roca JH Murphy DR Rubinow 2000 Estrogen replacement in perimenopause-related depression: a preliminary report Am J Obst Gynecol. 183 414 420 10.1067/mob.2000.106004 1:CAS:528:DC%2BD3cXmsFOgtrw%3D
49. C Schule F di Michele T Baghai E Romeo G Bernardi P Zwanzger F Padberg A Pasini R Rupprecht 2003 Influence of sleep deprivation on neuroactive steroids in major depression Neuropsychopharmacology 28 577 581 10.1038/sj.npp.1300084 12629540
50. M Serra MG Pisu L Dazzi RH Purdy G Biggio 2002 Prevention of the stress-induced increase in the concentration of neuroactive steroids in rat brain by long-term administration of mirtazapine but not of fluoxetine J. Psychopharmacol. 16 133 138 10.1177/026988110201600203 1:CAS:528: DC%2BD38XlsVejsbc%3D 12095071
51. CN Soares OP Almeida H Joffe LS Cohen 2001 Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial Arch. Gen. Psychiatry 58 529 534 10.1001/archpsyc.58.6.529 1:CAS:528:DC%2BD3MXltVGgsrs%3D 11386980
52. B Stoffel-Wagner 2001 Neurosteroid metabolism in the human brain European Journal of Endocrinology/European Federation of Endocrine Societies 145 669 679 1:CAS:528:DC%2BD3MXpt1Ghtrc%3D 11720889
53. A Strohle E Romeo B Hermann A Pasini G Spalletta F di Michele F Holsboer R Rupprecht 1999 Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery Biol. Psychiatry 45 274 277 10.1016/S0006-3223(98)00328-X 1:CAS:528:DyaK1MXhtlSiuro%3D 10023501 (Pubitemid 29100030)
54. A Strohle A Pasini E Romeo B Hermann G Spalletta F di Michele F Holsboer R Rupprecht 2000 Fluoxetine decreases concentrations of 3 alpha, 5 alpha-tetrahydrodeoxycorticosterone (THDOC) in major depression J. Psychiatr. Res. 34 183 186 10.1016/S0022-3956(00)00006-6 1:STN:280:DC%2BD3cvgsFKksw%3D%3D 10867112 (Pubitemid 30364917)
55. RD Strous R Maayan A Weizman 2006 The relevance of neurosteroids to clinical psychiatry: from the laboratory to the bedside Eur. Neuropsychopharmacol. 16 155 169 10.1016/j.euroneuro.2005.09.005 1:CAS:528:DC%2BD28Xit1Chu7g%3D 16257183 (Pubitemid 43358006)
56. M Takebayashi A Kagaya Y Uchitomi A Kugaya M Muraoka N Yokota J Horiguchi S Yamawaki 1998 Plasma dehydroepiandrosterone sulfate in unipolar major depression. Short communication J Neural Transm 105 537 542 10.1007/ s007020050077 1:STN:280:DyaK1czosF2gtw%3D%3D 9720981 (Pubitemid 28365036)
57. GD Tollefson E Haus MJ Garvey M Evans VG Tuason 1990 24-Hour urinary dehydroepiandrosterone sulfate in unipolar depression treated with cognitive and/or pharmacotherapy Ann. Clin. Psychiatry 2 39 45 10.3109/10401239009150005
58. V Uzunova Y Sheline JM Davis A Rasmusson DP Uzunov E Costa A Guidotti 1998 Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine Proceedings of the National Academy of Sciences of the USA 95 3239 3244 10.1073/pnas.95.6.3239 1:CAS:528:DyaK1cXitV2itbo%3D 9501247 (Pubitemid 28135886)
59. V Uzunova M Ceci C Kohler DP Uzunov AS Wrynn 2003 Region-specific dysregulation of allopregnanolone brain content in the olfactory bulbectomized rat model of depression Brain Res. 976 1 8 10.1016/S0006-8993(03)02577-0 1:CAS:528:DC%2BD3sXjvV2mu7c%3D 12763616 (Pubitemid 36588530)
60. V Uzunova AS Wrynn A Kinnunen M Ceci C Kohler DP Uzunov 2004 Chronic antidepressants reverse cerebrocortical allopregnanolone decline in the olfactory-bulbectomized rat Eur. J. Pharmacol. 486 31 34 10.1016/j.ejphar.2003. 12.002 1:CAS:528:DC%2BD2cXnvVOrtQ%3D%3D 14751405 (Pubitemid 38130158)
61. V Uzunova L Sampson DP Uzunov 2006 Relevance of endogenous 3alpha-reduced neurosteroids to depression and antidepressant action Psychopharmacology 186 351 361 10.1007/s00213-005-0201-6 1:CAS:528:DC%2BD28XkvFCrtb4%3D 16249906 (Pubitemid 43800837)
62. F Van Broekhoven RJ Verkes 2003 Neurosteroids in Depression A review Psychopharmacology 165 97 110
63. L Westlund Tam BL Parry 2003 Does estrogen enhance the antidepressant effects of fluoxetine? J. Affect. Disord. 77 87 92 10.1016/S0165-0327(02)00357-9 1:CAS:528:DC%2BD3sXnvFShurs%3D 14550939 (Pubitemid 37205155)
64. OM Wolkowitz VI Reus E Roberts F Manfredi T Chan S Ormiston R Johnson J Canick L Brizendine H Weingartner 1995 Antidepressant and cognition-enhancing effects of DHEA in major depression Ann NY Acad Sci. 29 774 337 339
65. OM Wolkowitz VI Reus A Keebler N Nelson M Friedland L Brizendine E Roberts 1999 Double-blind treatment of major depression with dehydroepiandrosterone Am. J. Psychiatry 156 646 649 1:STN:280: DyaK1M3hs1Omug%3D%3D 10200751
66. K Yaffe B Ettinger A Pressman D Seeley M Whooley C Schaefer S Cummings 1998 Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: A prospective study Biol. Psychiatry 43 694 700 10.1016/S0006-3223(97) 00303-X 1:CAS:528:DyaK1cXjt1Slt7g%3D 9583004 (Pubitemid 28222391)
67. SS Yen AJ Morales O Khorram 1995 Replacement of DHEA in aging men and women. Potential remedial effects Ann NY Acad Sci 774 128 142 10.1111/j.1749-6632.1995.tb17377.x 1:CAS:528:DyaK28XjtVCks7Y%3D 8597453 (Pubitemid 26140365)
68. JE Zweifel WH Obrien 1997 Meta-analysis of the effect of hormone replacement therapy upon depressed mood Psychoneuroendocrinology 22 189 212 10.1016/S0306-4530(96)00034-0 1:CAS:528:DyaK2sXksVWrsr4%3D 9203229 (Pubitemid 27293623)